Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity

INTRODUCTION: Advanced non-small cell lung cancer (NSCLC) is still a therapeutic challenge as the 5-year survival is under 30%. The optimal treatment regimen is still under debate. HYPOTHESIS: Neo adjuvant (NA) treatment given pre-pneumonectomy does not increase surgical complexity or peri-OP mortal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cardiothorac Surg
Main Authors: Dan, Aravot, Yaron, Barac D., Efrat, Krutzwald-Josefson, Allen Aaron, M., Dov, Flex, Nir, Peled, Kramer Mordechai, R., Yuri, Peysakhovich, Milton, Saute
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327573/
https://ncbi.nlm.nih.gov/pubmed/30626407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13019-018-0829-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados